维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Cavenagh JD"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	反应停治疗多发性骨髓瘤的现况与展望显示文摘1 引言 20世纪50年代,反应停作为一种镇静剂进入欧洲市场,且发现其对减轻孕妇晨吐症状特别有效.众所周知,在认识了它的致畸作用,尤其是引起短肢畸形后,于1961年被停止使用.	Cavenagh JD Oakervee H 徐泽锋肖志坚郝玉书	2003	国外医学(输血及血液学分册)2003，26，1：	11
2	Use of bortezomib as induction therapy prior to stem cell transplantation in frontline treatment of multiple myeloma:impact on stem cell harvesting and engraftment显示文摘	Oakervee H Popat R Cavenagh JD		0，，：	1
3	Mutation of CEBPA in Familial Acute Myeloid Leukemia 显示文摘	Smith ML Cavenagh JD Lister TA	2004	The New England Journal of Medicine2004，351，23：	1
4	Thlidomide in multiple myeloma: current status and future prospects显示文摘	Cavenagh JD Oakervee H	2003	Br J Haematol2003，120，：	1
5	Mutation of CEBPA in familial acute myeloid leukemia显示文摘	Smith ML Cavenagh JD Lister TA	2004	N Engl J Med2004，351，23：	1
6	Low dose antithymoeyte globulin for the treatment of older patients with aplastic anaemia 显示文摘	Killick SB Cavenagh JD Davies JK	2006	Leuk Res2006，30，12：	1
7	Protein A immunoadsorption in chronic refractory ITP reverses increased platelet activation but fails to achieve sustained clinical benefit显示文摘	Cahill MR Macey MG Cavenagh JD	1998	Br J Haematol1998，100，2：	1
8	Thalidomide in multiple myeloma : Current status and future prospects显示文摘	Cavenagh JD Oakervee H	2003	Br J Haematol2003，120，1：	1
9	Use of hortezomib as induction therapy prior to stem cell transplantation in frontline treatment of mul- tiple myeloma: impact on stem cell harvesting and engraftment 显示文摘	Oakervee H Popat R Cavenagh JD	2007	Leukemia Lymphoma2007，48，10：	1
10	A phase 2 study of the safety and efficacy of fituximab with plasma ex change in acute acquired thrombotic thrombooytopenic purpura显示文摘	SCULLY M MCDONALD V CAVENAGH JD et at	2011	Blood2011，118，7：	1
11	Adhesion molecule expression on CD34+ progenitor cells from normal and aplastic anaemia bone marrow 显示文摘	Karakantza M Cavenagh JD Gordon-Smith EC	1995	Br J Haematol1995，91，4：	1
12	Thalidomide in multiple myeloma:Carrent status and future prospects显示文摘	Cavenagh JD Oakervee H	2003	Brit J Hematol2003，120，：	1
13	Low dose anti - thymocyte globulin for the treatment of older patients with aplastic anaemia显示文摘	Killick SB Cavenagh JD Davies JK	2006	Leuk Res2006，30，12：	1
14	A pilot study of antithymocyte globulin (ATG) in the treatment of patients with ′low-risk′ myelodysplasia显示文摘	Killick SB Mufti G Cavenagh JD	2003	Br J Haematol2003，120，4：	1
15	Protein A immunoad-sorption in chronic refractory ITP reverses increased platelet activa- tion but fails to achieve sustained clinical benefit显示文摘	Cahill MR Macey MG Cavenagh JD	1998	Br J Haema- to11998，100，2：	1
16	Low dose antithymo- cyte globulin for the treatment of older patients with aplastic anaemia显示文摘	Killick SB Cavenagh JD Davies JK	2006	Leuk Res2006，30，12：	1
17	Thalidomide in multiple myeloma:cur- rent status and future prospects 显示文摘	Cavenagh JD Oakervee H	2003	Br J Haematol2003，120，：	1
18	Guideline thalidomide in multiple myeloma:current status and future prospects显示文摘	Cavenagh JD Oakervee H	2003	Br J Haematol2003，120，：	1
19	Serum LDH,a prognostic factor in elderly patients with acute myelogenous leukaemia显示文摘	Dalley CD Lister TA Cavenagh JD	2001	Br J Cancer2001，84，1：	1
20	显示文摘	Karakantza M Cavenagh JD Gordon-Smith EC	1995	Br J Haematol1995，91，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示